Medical and pharmaceutical studies in animals are not an end in and of themselves. They are justified because they improve the health and well-being of humans, and also of animals, depending on the product to be developed. Most drugs used in sick or injured animals are often just slight variations of human medicines. Active ingredients such as antibiotics, analgesics, anti-inflammatory and cancer drugs are used equally in human and veterinary medicine.
Conducting animal studies always demands a high level of responsibility. Animals must be spared any unnecessary suffering. All Bayer employees involved in animal studies are educated about this and receive appropriate training in order to meet this important requirement.
Animals are our fellow creatures and must be protected and treated accordingly. This is the ethical basis for legal requirements and for Bayer’s principles. Animal studies may only be conducted if they are expected to be of significant benefit to the health of humans and animals. At Bayer, it goes without saying that everything is done to minimize any suffering by animals. And all new studies are carefully reviewed to make sure they are really necessary. One of the consequences of these efforts is that the number of laboratory animals at Bayer has decreased continuously in recent years.